Clinical Report: Study Finds CME Prevalence in RP is Gene-Dependent
Overview
A recent study identified significant associations between specific genetic mutations and the development of cystoid macular edema (CME) in patients with nonsyndromic retinitis pigmentosa (RP). The findings highlight the importance of genetic factors, particularly mutations in splicing factor genes, in predicting CME prevalence.
Background
Cystoid macular edema is a common complication in retinitis pigmentosa, which can lead to vision loss. Understanding the genetic underpinnings of CME can enhance patient management and inform therapeutic strategies. This study provides critical insights into the gene-dependent nature of CME risk in RP patients.
Data Highlights
| Inheritance Pattern | CME Prevalence |
|---|---|
| Autosomal Dominant | 51.4% |
| Autosomal Recessive | 28.1% |
| X-linked | 7.5% |
Key Findings
- 30.9% of RP patients developed CME during the disease course.
- CME prevalence was highest in patients with mutations in PRPF3 (75%) and PRPF8 (72.7%).
- Females showed a higher initial CME rate (39.4%) compared to males (25%), but this difference was not significant after adjusting for inheritance pattern.
- Variants in RHO, such as p.Arg135Trp and p.Pro347Leu, were frequently linked to CME.
- Genes encoding splicing factors demonstrated a 57.7% CME prevalence, suggesting a role in CME pathogenesis.
Clinical Implications
The findings underscore the necessity of genetic testing in RP patients to identify those at higher risk for CME. Clinicians should consider incorporating spectral-domain optical coherence tomography (SD-OCT) assessments into routine evaluations to monitor retinal changes and optimize management strategies.
Conclusion
This study emphasizes the importance of genetic factors in the development of CME in RP patients and highlights the need for further research to explore underlying mechanisms and potential therapeutic targets.
References
- Testa F., et al., Investigative Ophthalmology & Visual Science, 2025 -- Study Finds CME Prevalence in RP is Gene-Dependent
- Clinical Rheumatology — Clinical Characteristics and Associated Risk Factors of Raynaud's Phenomenon in Patients with Primary Sjögren's Syndrome
- The Journal of Clinical Endocrinology & Metabolism — In-Depth Analysis of Central Precocious Puberty: Genetic and Clinical Evaluations in a Cohort of 90 Patients
- Clinical Rheumatology — An epidemiological study estimating the burden of cancer risk in patients with Raynaud’s phenomenon
- Blood Cancer Journal — Meta-analysis Across the Genome Reveals Risk Loci Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) and IRF-6 Impact
- Study Finds CME Prevalence in RP is Gene-Dependent | Retinal Physician
- https://eplatform.euretina.org/wp-content/uploads/2025/10/EURETINA_IRD-Consensus-Supplement.pdf
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
